Conversion Resection or Direct Resection for Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicentre Study
Preoperative conversion therapy could significantly improve pathological responses and long-term survival outcomes in intermediate-stage HCC patients.
Authors
- Weixia Chen
- Tianfu Wen (ORCID: https://orcid.org/0000-0003-1871-272X)
- Ying Zhou (ORCID: https://orcid.org/0000-0003-4553-4367)
- Mao-Lin Yan (ORCID: https://orcid.org/0000-0002-9852-2661)
- Wusheng Lu (ORCID: https://orcid.org/0000-0003-0100-3804)
- Jiayi Wu (ORCID: https://orcid.org/0000-0001-5371-8989)
- Q. Li (ORCID: https://orcid.org/0009-0005-8196-0082)
- Xielin Feng
- Junyi Shen (ORCID: https://orcid.org/0000-0003-2206-5078)
- Xiaoyun Zhang (ORCID: https://orcid.org/0000-0003-1257-379X)
- Haiqing Wang (ORCID: https://orcid.org/0000-0002-6805-2283)
- Ji Ma
Institutions
- Fujian Medical University (CN)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Sichuan Cancer Hospital (CN)
Publication Details
- Journal
- Liver Cancer
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1159/000549684
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sichuan University
- West China Hospital, Sichuan University